58
Views
13
CrossRef citations to date
0
Altmetric
Review

Stimulus-controlled delivery of drugs and genes

, , &
Pages 653-665 | Published online: 11 Aug 2005

Bibliography

  • DUNCAN R: The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. (2003) 2:347–360.
  • GOPIN A, PESSAH N, SHAMIS M, RADER C, SHABAT D: A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger. Angew. Chem. Int. Ed. (2003) 42:327–332.
  • SHABAT D, RADER C, LIST B, LERNER RA, BARBAS CF 3rd: Multiple event activation of a generic prodrug trigger by antibody catalysis. Proc. Natl. Acad. Sci. USA (1999) 96:6925–6930.
  • GIANASI E, WASIL M, EVAGOROU EG, KEDDLE A, WILSON G, DUNCAN R: HPMA copolymer platinates as novel antitumour agents: in vitro properties, pharmacokinetics and antitumour activity in vivo. Eur. j Cancer (1999) 35:994–1002.
  • SAITO G, SWANSON JA, LEE KD: Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. (2003) 55:199–215.
  • •A comprehensive review of drug delivery systems sensitive to redox potential gradients.
  • KRETZ-REMY C, ARRIGO AP: Gene expression and thiol redox state. Methods Enzymol. (2002) 348:200–215.
  • MEISTER A. ANDERSON ME: Glutathione. Ann. Rev. Biochem. (1983) 52:711–760.
  • BELLOMO G, VAIRETTI M, STIVALA L, MIRABELLI F, RICHELMI P, ORRENIUS S: Demonstration of nuclear compartmentalization of glutathione in hepatocytes. Proc. Nail. Acad. Sci. USA (1992) 89:4412–4416.
  • ARRIGO AP: Gene expression and the thiol redox state. Free Radic. Biol. Med. (1999) 27:936–944.
  • AULT JG, LAWRENCE DA: Glutathione distribution in normal and oxidatively stressed cells. Exp. Cell Res. (2003) 285:9–14.
  • ARRICK BA, NATHAN CF: Glutathione metabolism as a determinant of therapeutic efficacy. Cancer Res. (1984) 44:4224–4232.
  • WU X, BISHOPRIC NH, DISCHER DJ, MURPHY BJ, WEBSTER KA: Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol. (1996) 16: 1035–1046.
  • HWANG C, LODISH HF, SINSKEY AJ:Measurement of glutathione redox state in cytosol and secretory pathway of cultured cells. Methods Enzymol (1995) 251:212–221.
  • HWANG C, SINSKEY AJ, LODISH HF:Oxidized redox state of glutathione in the endoplasmic reticulum. Science (1992) 257:1496–1502.
  • LASH LH, PUTT DA, HUENI SE et al.:Cellular energetics and glutathione status in NRK-52E cells: toxicological implications.Biochem. Pharmacol (2002) 64:1533–1546.
  • STAAL FJT, ROEDERER M, HERZENBERG LA: Intracellular thiols regulate activation of nuclear factor kappa-B and transcription of human-immunodeficiency-virus. Proc. Natl Acad. Sci. USA (1990) 87:9943–9947.
  • TOWNSEND DM, TEW KD, TAPIERO H: The importance of glutathione in human disease. Biomed. Pharmacother. (2003) 57:145–155.
  • COLLINS DS, UNANUE ER, HARDING CV: Reduction of disulfide bonds within lysosomes is a key step in antigen processing. J. Immunol. (1991) 147: 4054–4059.
  • DONOGHUE N, YAM PTW, JIANG XM, HOGG PJ: Presence of closely spaced protein thiols on the surface of mammalian cells. Protein Sci. (2000) 9:2436–2445.
  • PHAN UT, ARUNACHALAM B, WELL P: Gamma-interferon-inducible lysosomal thiol reductase (GILT) - maturation, activity, and mechanism of action. J. Biol. Chem. (2000) 275:25907–25914.
  • VOEHRINGER DW: BCL-2 and glutathione: alterations in cellular redox state that regulate apoptosis sensitivity. Free Radic. Biol. Med. (1999) 27:945–950.
  • VOEHRINGER DW, MCCONKEY DJ, MCDONNELL TJ, BRISBAY S, MEYN RE: Bc1-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA (1998) 95:2956–2960.
  • VOEHRINGER DW, MEYN RE: Redox aspects of Bc1-2 function. Antioxid. Redox Signal. (2000) 2:537–550.
  • SIES H: Glutathione and its role in cellularfunctions. Free Radic. Biol. Med. (1999) 27:916–921.
  • FITZGERALD UF, GILBEY T, BRODIE S, BARNETT SC: Transcription factor expression and cellular redox in immature oligodendrocyte cell death: effect of Bc1-2. MoL Cell. Neurosci. (2003) 22:516–529.
  • ORTEGA A, FERRER P, CARRETERO Jet al.: Down-regulation of glutathione and Bc1-2 synthesis in mouse B16 melanoma cells avoids their survival during interaction with the vascular endothelium. J. Biol. Chem. (2003) 278:39591–39599.
  • HOETELMANS RW, VAHRMEIJER AL, MULDER GJ, VAN VELDE CJ, NAGELKERKE JF, VAN DIERENDONCK Bc1-2 overexpression does not prevent but retards adriamycin toxicity in CC531 colon carcinoma cells. Chemotherapy (2003) 49:309–315.
  • HOETELMANS RW, VAHRMEIJER AL, VAN VLIERBERGHE RL et al.: The role of various Bc1-2 domains in the anti-proliferative effect and modulation of cellular glutathione levels: a prominent role for the BH4 domain. Cell Prolif (2003) 36:35–44.
  • STORY MD, MEYN RE: Modulation of apoptosis and enhancement of chemosensitivity by decreasing cellular thiols in a mouse B-cell lymphoma cell line that overexpresses bc1-2. Cancer Chemother. Pharmacol (1999) 44:362–366.
  • MIRKOVIC N, VOEHRINGER DW, STORY MD, MCCONKEY DJ, MCDONNELL TJ, MEYN RE: Resistance to radiation-induced apoptosis in Bc1-2-expressing cells is reversed by depleting cellular thiols. Oncogene (1997) 15:1461–1470.
  • AMICHETTI M, ROMANO M, CRISTOFORETTI L, VALDAGNI R: Hyperthermia and radiotherapy for inoperable squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site. Int. J. Hyperthermia (2000) 16:85–93.
  • VALDAGNI R, AMICHETTI M: Report of long-term follow-up in a randomized trial comparing radiation therapy and radiation therapy plus hyperthermia to metastatic lymph nodes in stage IV head and neck patients. Int. J. Radiat. Oncol Biol. Phys. (1994) 28:163–169.
  • OVERGAARD J, GONZALEZ D, HULSHOF MC et al.: Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology. Lancet (1995) 345:540–543.
  • LI G, MITSUMORI M, OGURA M et al.:Local hyperthermia combined with external irradiation for regional recurrent breast carcinoma. Int. J. Clin. Oncol (2004) 9:179–183.
  • ROTHBARTH J, TOLLENAAR RA, SCHELLENS JH et al.: Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives. Eur. j Cancer (2004) 40:1812–1824.
  • FELDMAN ED, WU PC, BERESNEVA T et al.: Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion. J. Gastrointest. Surg-. (2004) 8:200–207.
  • GLEHEN O, MOHAMED F, GILLY FN: Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol (2004) 5:219–228.
  • BORRELLI MJ, SCHOENHERR DM, WONG A, BERNOCK LJ, CORRY PM: Heat-activated transgene expression from adenovirus vectors infected into human prostate cancer cells. Cancer Res. (2001) 61:1113–1121.
  • BRADE AM, SZMITKO P, NGO D, LIU FF, KLAMUT HJ: Heat-directed suicide gene therapy for breast cancer. Cancer Gene Ther. (2003) 10:294–301.
  • WUST P, HILDEBRANDT B, SREENIVASA G et al.: Hyperthermia in combined treatment of cancer. Lancet Oncol (2002) 3:487–497.
  • HYNYNEN K, CLEMENT GT, MCDANNOLD N et al.: 500-Element ultrasound phased array system for noninvasive focal surgery of the brain: a preliminary rabbit study with ex vivo human skulls. Magn. Reson. Med. (2004) 52:100–107.
  • MILLER DL, PISLARU SV, GREENLEAF JE: Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat. Cell Mot Genet. (2002) 27:115–134.
  • TANIYAMA Y, TACHIBANA K, HIRAOKA K et al.: Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. (2002) 9:372–380.
  • SKYBA DM, PRICE RJ, LINKA AZ, SKALAK TC, KAUL S: Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation (1998) 98:290–293.
  • UNGER EC, MATSUNAGA TO, MCCREERY T, SCHUMANN P, SWEITZER R, QUIGLEY R: Therapeutic applications of microbubbles. Eur. J. Radiol. (2002) 42:160–168.
  • PRICE RJ, SKYBA DM, KAUL S, SKALAK TC: Delivery of colloidal, particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation (1998) 98:1264–1267.
  • ••Demonstration of efficient enhancement of vascular extravasation of synthetic nanoparticles by localised ultrasound treatment.
  • HYNYNEN K, MCDANNOLD N, VYKHODTSEVA N, JOLESZ FA: Non-invasive opening of BBB by focused ultrasound. Acta Neurochir. Suppl (2003) 86:555–558.
  • LINDNER JR, KAUL S: Delivery of drugswith ultrasound. Echocardiography (2001) 18:329–337.
  • MILLER DL, SONG J: Lithotripter shock waves with cavitation nucleation agents produce tumor growth reduction and gene transfer in vivo. Ultrasound Med. Biol. (2002) 28:1343–1348.
  • SONG J, CHAPPELL JC, QI M, VANGIESON EJ, KAUL S, PRICE RJ: Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J. Am. Coll. Cardiol. (2002) 39:726–731.
  • LI P, ARMSTRONG WF, MILLER DL: Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents. Ultrasound Med. Biol. (2004) 30:83–91.
  • PITT WG, HUSSEINI GA, STAPLES BJ: Ultrasonic drug delivery - a general review. Expert Opin. Drug Deliv. (2004) 1:37–56.
  • KWOK KY, PARK Y, YANG Y, MCKENZIE DL, LIU Y, RICE KG: In vivo gene transfer using sulfhydryl cross-linked PEG-peptide/glycopeptide DNA co-condensates. J. Pharm. Sci. (2003) 92:1174–1185.
  • OUPICKY D, OGRIS M, HOWARD KA, DASH PR, ULBRICH K, SEYMOUR LW: Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation. Mol. Ther. (2002) 5:463–472.
  • OUPICKY D, PARKER AL, SEYMOUR LW: Laterally stabilized complexes of DNA with linear reducible polycations: Strategy for triggered intracellular activation of DNA delivery vectors./ Am. Chem. Soc. (2002) 124:8–9.
  • •Strategy for specific intracellular activation of DNA polyplexes stabilised by surface crosslinking with multivalent copolymers.
  • FISHER KD, ULBRICH K, SUBR V et al.: A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Ther. (2000)7:1337-1343.
  • DASH PR, READ ML, FISHER K et al.: Decreased binding to proteins and cells of polymeric gene delivery vectors surface modified with a multivalent hydrophilic polymer and retargeting through attachment of transferrin. j Biol. Chem. (2000) 275:3793–3802.
  • CARLISLE RC, ETRYCH T, BRIGGS SS, PREECE JA, ULBRICH K, SEYMOUR LW: Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J. Gene. Med. (2004) 6:337–344.
  • BALAKIREV M, SCHOEHN G, CHROBOCZEK J: Lipoic acid-derived amphiphiles for redox-controlled DNA delivery. Chem. Biol. (2000) 7:813–819.
  • READ ML, BREMNER KH, OUPICKY D, GREEN NK, SEARLE PF, SEYMOUR LW: Vectors based on reducible polycations facilitate intracellular release of nucleic acids. J. Gene. Med. (2003) 5:232–245.
  • JARUGA E, BIELAK-ZMIJEWSKA A, SIKORA E et al.: Glutathione-independent mechanism of apoptosis inhibition by curcumin in rat thymocytes. Biochem. PharmacoL (1998) 56: 961–965.
  • LEVY EJ, ANDERSON ME, MEISTER A:Transport of glutathione diethyl ester into human cells. Proc. Nail. Acad. Sri. USA (1993) 90:9171–9175.
  • ANDERSON DM, HALL LL, AYYALAPU AR, IRION V11, NANTZ MH, HECKER JG: Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: Methods and evidence for nonviral mRNA gene delivery to the central nervous system. Hum. Gene Ther. (2003) 14:191–202.
  • MITCHELL DA, NAIR SK: RNA-transfected dendritic cells in cancer immunotherapy. J. Clin. Invest. (2000) 106:1065–1069.
  • HEISER A, DAHM P, YANCEY DR et al.: Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J. Immunol (2000) 164:5508–5514.
  • MALONE RW, FELGNER PL, VERMA IM: Cationic Liposome-Mediated RNA Transfection. Proc. Natl. Acad. Sci. USA (1989) 86:6077–6081.
  • BETTINGER T, CARLISLE RC, READ ML, OGRIS M, SEYMOUR LW: Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. Nucleic Acids Res. (2001) 29:3882–3891.
  • •High molecular weight polycations are not compatible with mRNA transfection.
  • ZOU SM, ERBACHER P, REMY JS, BEHR JP: Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse./ Gene. Med. (2000) 2:128–134.
  • CHOLLET P, FAVROT MC, HURBIN A. COLL JL: Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J. Gene. Med. (2002) 4:84–91.
  • FISCHER D, LI Y, AHLEMEYER B, KRIEGLSTEIN J, KISSEL T: In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterieds (2003) 24:1121–1131.
  • LEROY D, SCHMID N, BEHR JP et al.:Direct identification of a polyamine binding domain on the regulatory subunit of the protein-kinase casein kinase-2 by photoaffinity-labeling. J. Biol. Chem. (1995) 270:17400–17406.
  • CHOKSAKULNIMITR S, MASUDA S, TOKUDA H, TAKAKURA Y, HASHIDA M: In-vitro cytotoxicity of macromolecules in different cell-culture systems. J. Control. Release (1995) 34:233–241.
  • SINGH AK, KASINATH BS, LEWIS EJ: Interaction of polycations with cell-surface negative charges of epithelial-cells. Biochim. Biophys. Acta (1992) 1120:337–342.
  • MORGAN DML, LARVIN V1,, PEARSON JD: Biochemical-characterization of polycation-induced cyto-toxicity to human vascular endothelial-cells. J. Cell Sci. (1989) 94:553–559.
  • BIEBER T, MEISSNER W, KOSTIN S, NIEMANN A, ELSASSER HP: Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J. Control. Release (2002) 82:441–454.
  • GODBEY WT, WU KK, MIKOS AG: Poly(ethylenimine)-mediated gene delivery affects endothelial cell function and viability. Biomaterieds (2001) 22:471–480.
  • GODBEY WT, WU KK, MIKOS AG: Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res. (1999) 45:268–275.
  • FISCHER D, BIEBER T, LI YX, ELSASSER HP, KISSEL T: A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. (1999) 16:1273–1279.
  • BRISSAULT B, KICHLER A, GUIS C, LEBORGNE C, DANOS 0, CHERADAME H: Synthesis of linear polyethylenimine derivatives for DNA transfection. Bioconjugate Chem. (2003) 14:581–587.
  • MORGAN DML, CLOVER J, PEARSON JD: Effects of synthetic polycations on leucine incorporation, lactate-dehydrogenase release, and morphology of human umbilical vein endothelial-cells. J. Cell Sri. (1988) 91: 231–238.
  • MANICKAM D, BISHT HS, WAN L, MAO G, OUPICKY D: Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes. J. Control. Release (2005) 102:293–306.
  • MEYER DE, SHIN BC, KONG GA, DEWHIRST MW, CHILKOTI k Drug targeting using thermally responsive polymers and local hyperthermia. J. Control. Release (2001) 74:213–224.
  • KURISAWA M, YOKOYAMA M, OKANO T: Gene expression control by temperature with thermo responsive polymeric gene carriers. J. Control. Release (2000) 69:127–137.
  • •First published evidence of temperature-controlled transfection activity of non-viral vectors using temperature-responsive copolymers.
  • OUPICKY D, RESCHEL T, KONAK C, OUPICKA L: Temperature controlled behavior of self-assembly gene delivery vectors based on complexes of DNA with poly-L-lysine-graft-poly-N-isopropylacrylamide). Macromolecules (2003) 36:6883–6872.
  • •Demonstration of the possibility to control biophysical properties of DNA polyplexes by temperature-responsive copolymers.
  • KONAK C, RESCHEL T, OUPICKY D, ULBRICH K: Thermally controlled association in aqueous solutions of poly(L-lysine) grafted with poly (N-isopropylacrylamide). Langmuir (2002) 18:8217–8222.
  • TWAITES BR, DE LAS ALARCON C, CUNLIFFE D et al.: Thermo and pH responsive polymers as gene delivery vectors: effect of polymer architecture on DNA complexation in vitro. J. Control. Release (2004) 97:551–566.
  • TURK M, DINCER S, YULUG IG, PISKIN E: In vitro transfection of HeLa cells with temperature sensitive polycationic copolymers. J. Control. Release (2004) 96:325–340.
  • KURISAWA M, YOKOYAMA M, OKANO T: Transfection efficiency increases by incorporating hydrophobic monomer units into polymeric gene carriers. J. Control. Release (2000) 68:1–8.
  • BULMUS V, DING ZL, LONG CJ, STAYTON PS, HOFFMAN AS: Site-specific polymer-streptavidin bioconjugate for pH-controlled binding and triggered release of biotin. Bioconjugate Chem. (2000) 11:78–83.
  • DING Z, LONG CJ, HAYASHI Y, BULMUS EV, HOFFMAN AS, STAYTON PS: Temperature control of biotin binding and release with a streptavidin-poly(N-isopropylacrylamide) site-specific conjugate. Bioconjugate Chem. (1999) 10:395–400.
  • DING ZL, FONG RB, LONG CJ, STAYTON PS, HOFFMAN AS: Size-dependent control of the binding of biotinylated proteins to streptavidin using a polymer shield. Nature (2001) 411:59–62.
  • ••Temperature-responsive copolymers control binding of protein substrates in a size-dependent manner.
  • STAYTON PS, SHIMOBOJI T, LONG C et al.: Control of protein-ligand recognition using a stimuli-responsive polymer. Nature (1995) 378:472–474.
  • SHIMOBOJI T, LARENAS E, FOWLER T, HOFFMAN AS, STAYTON PS: Temperature-induced switching of enzyme activity with smart polymer-enzyme conjugates. Bioconjugate Chem. (2003) 14:517–525.
  • PENNADAM SS, FIRMAN K, ALEXANDER C, GORECKI DC: Protein-polymer nano-machines. Towards synthetic control of biological processes. Nanobiotech. (2004) 2:8.
  • PENNADAM SS, LAVIGNE MD, DUTTA CF et al.: Control of a multisubunit DNA motor by a thermoresponsive polymer switch. J. Am. Chem. Soc. (2004) 126:13208–13209.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.